Antares Pharma, Inc.
FDA inspection history in Minnetonka, Minnesota, 2018 to 2022
- 2
- Form 483s
Every document, by year
- Form 483
2018: one Form 483; 2022: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2018One Form 483, at Minnetonka, Minnesota.
- 2022One Form 483, at Minnetonka, Minnesota.
- 2022The longest 483 on file: 1 observation over 3 pages at Minnetonka, Minnesota.
Cited most
Across all Antares Pharma observations on file
- 21 CFR 820.100(b)Corrective and preventive action1
- 21 CFR 820.30Design controls1
The complete Antares Pharma file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Minnetonka, Minnesota
Two Form 483s · 2018 to 2022 · 2 observations
Latest: Form 483, May 13, 2022 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2022-05-13 | 483 Form 483 | Minnetonka, Minnesota | 1 | $99 |
| 2018-12-04 | 483 Form 483 | Minnetonka, Minnesota | 1 | $99 |
Investigators on these documents
FEI number 2182861 · most recent document May 13, 2022
About Antares Pharma, Inc.
How many FDA Form 483s has Antares Pharma, Inc. received?
FDA Intel has 2 Form 483s on file for Antares Pharma, Inc.; the most recent is dated May 13, 2022.
When was Antares Pharma, Inc. last inspected by FDA?
The most recent FDA inspection document on file for Antares Pharma, Inc. is a Form 483 dated May 13, 2022, for the site in Minnetonka, Minnesota.
What did FDA cite at Antares Pharma, Inc.?
The regulations cited most in the observations on file for Antares Pharma, Inc. are 21 CFR 820.100(b) (Corrective and preventive action), 1 time; 21 CFR 820.30 (Design controls), 1 time.